TotalMarketCap

Incannex Healthcare

IXHLNasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$28.602 M

$2.28 -8.43%

Close of 6 Nov 2026

As of 6 Nov 2026, Incannex Healthcare (IXHL) has a market capitalization of $28.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$12.0K

#3602 by revenue

Earnings

-$46.9M

Loss-making

Shares outstanding

12,544,627

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #364Edesa BiotechEDSA$28.9M
  2. #365BriaCell TherapeuticsBCTX$28.7M
  3. #366Incannex HealthcareIXHL$28.6M
  4. #367Annovis BioANVS$28.1M
  5. #368Adicet BioACET$27.6M

What if Incannex Healthcare were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,250,914

Per share 987,243× higher

Bitcoin $1.53T

$121,793.02

Per share 53,418× higher

Apple $5.02T

$399,835.13

Per share 175,366× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Incannex Healthcare are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.